All You Need To Know About Merck’s Covid Pill Molnupiravir

Molnupiravir was developed for the treatment of Influenza. According to whistleblower complaint Molnupiravir has mutagenic properties and may change your DNA. Now, Molnupiravir has been repurposed for COVID-19. Merck has entered into agreements with Indian manufacturers and has also announced $5 million of donations to enter into Indian market. Here is all you need to know about Merck’s Covid pill Molnupiravir.

The World Won’t Be the Same: How Coronavirus Changed Our Lives

The rapidly spreading coronavirus infection in the spring of 2020 forced all countries to take unprecedented action. Self-isolation and travel restrictions were accompanied by alarming news of increasing numbers of cases and difficult-to-treat symptoms of the virus. This forced people to pay more attention to their health and hygiene. Today it is safe to say […]